Artiva Biotherapeutics, Inc.
ARTV
$3.64
$0.061.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.14% | 205.79% | 167.10% | 140.91% | -- |
| Total Receivables | -37.26% | -34.02% | -86.42% | -67.04% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 124.12% | 247.49% | 87.63% | 150.19% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.97% | 199.64% | 158.03% | 136.32% | -- |
|
|
|||||
| Total Current Assets | -13.97% | 199.64% | 158.03% | 136.32% | -- |
| Net Property, Plant & Equipment | -14.18% | -12.80% | -11.06% | -17.12% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 58.09% | -85.44% | -47.62% | -19.23% | -- |
| Total Assets | -34.01% | 123.14% | 112.13% | 99.38% | -- |
|
|
|||||
| Total Accounts Payable | -30.21% | 47.63% | 37.29% | 82.57% | -- |
| Total Accrued Expenses | -15.80% | -6.05% | 21.71% | -7.80% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.03% | -3.91% | 2.00% | 4.00% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -16.35% | -0.54% | 17.71% | 0.21% | -- |
|
|
|||||
| Total Current Liabilities | -16.35% | -0.54% | 17.71% | 0.21% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.17% | -19.98% | -18.52% | -20.29% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -99.71% | -- |
| Total Liabilities | -20.17% | -59.78% | -53.57% | -54.77% | -- |
|
|
|||||
| Common Stock & APIC | 1.78% | 1,896.84% | 2,036.80% | 2,182.78% | -- |
| Retained Earnings | -34.34% | -35.25% | -36.73% | -36.06% | -- |
| Treasury Stock & Other | -74.26% | -98.35% | -- | -141.88% | -- |
| Total Common Equity | -35.71% | 177.99% | 196.63% | 215.20% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.71% | 177.99% | 196.63% | 215.20% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.71% | 488.72% | 304.37% | 243.10% | -- |
|
|
|||||